Our focus remains simple—build and grow companies that are adding value to the healthcare system and enabling better outcomes for patients. With decades of history, we partner with management teams to deliver breakthrough innovation, reduce costs and expand access to high-quality care.
Hildred seeks opportunities to create value in healthcare companies with revenues of up to $100 million through short and long term strategic growth initiatives, margin expansion, financing, operational improvements, and M&A to drive earnings and cash flow, and the long term intrinsic value of companies.
Intensive research and thematic conviction are required prior to the initial review of any opportunity. We focus on secular healthcare trends and the companies that stand to benefit from them.
We actively identify companies using predetermined investment criteria. Our extensive network of industry experts and insiders is an essential component of our sustainable and successful deal sourcing. Potential deals must present clear operational improvement opportunities and attractive entry prices. We have a disciplined approach to reviewing every opportunity and keep holistic portfolio construction top of mind.
Operational improvements are at the core of our value creation approach. We identify value drivers in each company we own and develop a bespoke operational plan to drive revenue, earnings, and cash flow.
We define and execute growth strategies through either organic and/or M&A initiatives, invest in scalable infrastructure and teams, and align on a post-close strategy for continued growth.
At some point our portfolio companies will benefit from different ownership. The process for preparing and transitioning a business to a new owner is as rigorous as the one for buying that same business from the original owner. We reverse solve for the path to value creation so that our companies at exit are attractive and positioned for the long term.